AACR 2023: In vivo Efficacy Evaluation of Anti-Human VEGFR2 Antibodies in Humanized B-hVEGFR2 Mice

AACR 2023: In vivo Efficacy Evaluation of Anti-Human VEGFR2 Antibodies in Humanized B-hVEGFR2 Mice

 

Used in the poster: B-hVEGFR2 mice

Conclusions

  • mRNA expression analysis:
    Murine Vegfr2 mRNA was detected in embryonic tissue isolated from wild-type mice, while human VEGFR2 mRNA was detected in B-hVEGFR2 mice.
  • Protein expression analysis:
    Murine VEGFR2 protein was detected in wild-type mice, while human VEGFR2 protein was detected in B-hVEGFR2 mice.
  • In vivo efficacy:
    Anti-human VEGFR2 antibody was effective in controlling MC38 tumor growth in B-hVEGFR2 mice and inhibits vascular endothelial cell proliferation.

Share:

    Please fill out the form below to request a download of this poster